SDS Optic

SDS Optic AAQS

The The AAQS of SDS Optic (SDS.WA) as of Oct 30, 2026 is 3. In the previous year, The AAQS was 3.00 — a change of 0.00% (lower).

AAQS

3

YoY

0.00%

Last updated:

SDS Optic has a current AAQS of 3.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock SDS Optic in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The SDS Optic AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2019
3.00 PLN
Jan 1, 2020
3.00 PLN
Jan 1, 2021
3.00 PLN
Jan 1, 2022
3.00 PLN
Jan 1, 2023
3.00 PLN
Jan 1, 2024
3.00 PLN
The SDS Optic AAQS history
YEARAAQSYoY
30.00%
30.00%
30.00%
30.00%
30.00%
3—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SDS Optic Stock analysis

What does SDS Optic do? SDS Optic SA generates revenue by developing biochemistry, engineering, and fiber optic technology solutions specifically designed for cancer diagnosis and treatment. The company focuses its primary research activities on the oncology sector, aiming to improve upon current diagnostic methods that rely on biopsy and histopathology. By implementing the InProbe method, the firm offers a faster and more accurate alternative capable of providing results within 20 minutes to identify cancer markers. The company also conducts research into other diseases, such as fungal diseases, and collaborates with specialists from diverse fields including biology, medicine, technology, and sciences related to medicine. These partnerships support the development of advanced diagnostic tools, positioning the firm to serve the medical and scientific communities seeking improved early detection methods, particularly for breast cancer. SDS Optic is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SDS Optic stock

The AAQS of SDS Optic is 3 in 2024.

On Eulerpool you can find the complete historical development of The AAQS SDS Optic since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — SDS Optic

All Key Metrics — SDS Optic